Search
Showing results for "1"
Research
Genetic and functional evidence for a role for SLC11A1 in susceptibility to otitis media in early childhood in a Western Australian populationOtitis media (OM) is a common disease in early childhood characterised by inflammation of the middle ear.
Research
Genome-Wide Association Study to Identify the Genetic Determinants of Otitis Media Susceptibility in ChildhoodWe identified several novel candidate genes which warrant further analysis in cohorts matched more precisely for clinical phenotypes.
News & Events
Report finds most programs ineffective for Aboriginal childrenThe largest survey ever undertaken of Aboriginal children and families has thrown new light on why most existing intervention programs are failing.
Information from the Healthy Pregnancy & Me brochure for health professionals on how to raise the topic of gestational weight gain.
Research programs within the Life Course Centre.
News & Events
InFocus Interview: Kirsten Hancock on multigenerational disadvantage in AustraliaAn InFocus Research Interview with Kirsten Hancock of the Human Capability Team at The Kids Research Institute Australia on multigenerational disadvantage in Australia.
Research
Maximising fathers’ roles in preventing adolescent alcohol-related harm. (Fathers and Adolescent Alcohol Use Project)This project will explore fathers’ attitudes and behaviours regarding the alcohol-related parenting of 10-17-year-old children.
Research
Excess Mortality Among People With Rheumatic Heart Disease in AustraliaJonathan Carapetis AM AM MBBS FRACP FAFPHM PhD FAHMS Executive Director; Co-Head, Strep A Translation; Co-Founder of REACH 08 6319 1000 contact@
Research
A rapid review to inform the policy and practice for the implementation of chronic disease prevention and management programs for Aboriginal and Torres Strait Islander people in primary careMore than 35% of Aboriginal and Torres Strait Islander adults live with cardiovascular disease, diabetes, or chronic kidney disease. There is a pressing need for chronic disease prevention and management among Aboriginal and Torres Strait Islander people in Australia. Therefore, this review aimed to synthesise a decade of contemporary evidence to understand the barriers and enablers of chronic disease prevention and management for Aboriginal and Torres Strait Islander People with a view to developing policy and practice recommendations.
Research
Early treatment with fluvoxamine, bromhexine, cyproheptadine, and niclosamide to prevent clinical deterioration in patients with symptomatic COVID-19: a randomized clinical trialRepurposed drugs with host-directed antiviral and immunomodulatory properties have shown promise in the treatment of COVID-19, but few trials have studied combinations of these agents. The aim of this trial was to assess the effectiveness of affordable, widely available, repurposed drugs used in combination for treatment of COVID-19, which may be particularly relevant to low-resource countries.